Vita Life Sciences Ltd (vls) Logo

Vita Life Sciences Ltd (VLS)

___:___ · Healthcare
ASX Delayed
Cboe Live

What is live streaming pricing?

Stock prices will auto-update without reloading the page. How it works:

  • Flashing prices signify an increase (green) or decrease (red) from previous price. Otherwise, price is unchanged.
  • Expect a short delay while pricing data initially loads.
  • Note, prices only update during market hours (10am-4:13pm AEST).

More about Cboe Live pricing.

OK, got it
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE

VLS ASX Chart

Snapshot

Vita Life Sciences Limited (VLS) has a business of development and distribution of over the counter medicines, complementary and alternative medicines, dietary supplements and health foods under various brand names throughout Australia, South East Asia and China. Over 400 registered products, and around 300 employees. The Company have teams of qualified naturopaths, nutritionists, biotechnologists and pharmacists formulating products that are clean & functional.

Share Price Activity (ASX)

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2024 YTD
1 Year
vs Sector (1yr) +71.25%
vs ASX 200 (1yr) +60.41%

Size

Market Cap Question Mark Icon
Excludes mandatory escrowed shares and foreign shares.
ASX Rank 838 of 2,384
Sector Rank 62 of 226

Key Fundamentals

Shares Issued
Sector Healthcare
Similar Companies GSS / NXS / PKS
EPS $0.135
DPS $0.09
Book Value Per Share $0.656

Broker Consensus

VLS is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Announcements

Price Sensitive only

Corporate Overview

Corporate Details

Head Office Kirrawee NSW 2232
Website www.vitalifesciences.com
Registry Automic Group
Auditor Nexia Sydney Audit Pty Limited
Date Listed 23 Aug 2007

Upcoming Calendar (Forecasted)

Date Event
22/08/2024 Report (Interim)
24/02/2025 Report (Prelim)
17/03/2025 Report (Annual)

Former Company Names

  • Vita Life Sciences Limited (VSC), 31/08/2017

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
22/03/2024 $0.06 100% $0.0857 Final 12/04/2024
22/09/2023 $0.03 100% $0.0429 Interim 06/10/2023
17/03/2023 $0.0325 100% $0.0464 Final 14/04/2023
23/09/2022 $0.0275 100% $0.0393 Interim 07/10/2022
18/03/2022 $0.03 100% $0.0429 Final 07/04/2022
23/09/2021 $0.0275 100% $0.0393 Interim 08/10/2021
19/03/2021 $0.0275 100% $0.0393 Final 07/04/2021
24/09/2020 $0.015 100% $0.0214 Interim 09/10/2020
19/03/2020 $0.0225 100% $0.0321 Final 03/04/2020
24/09/2019 $0.015 100% $0.0214 Interim 08/10/2019
20/03/2019 $0.0225 100% $0.0321 Final 05/04/2019
24/09/2018 $0.015 100% $0.0214 Interim 08/10/2018
19/03/2018 $0.0225 100% $0.0321 Final 29/03/2018
21/09/2017 $0.015 100% $0.0214 Interim 05/10/2017

See Upcoming Dividends for all ASX companies.

Key Data
DPS(TTM) $0.09
Gross DPS(TTM) $0.1286
Dividend yield
Gross yield
Payout Ratio 54%
DRP Yes
DRP Features --

Directors & Management

Directors

Management

Director Transactions

VLS directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
12/04/24 Andrew O'Keefe Sell +920,000 $2.10 ($1,932,000) On-market trade
12/04/24 Henry Townsing Sell +100,000 $2.10 ($210,000) On-market trade
27/03/24 Henry Townsing Transfer 300,000 $1.89 $567,000 Off-market transfer
27/03/24 Henry Townsing Transfer 300,000 $1.89 $567,000 Off-market transfer
12/03/24 Peter Osborne Buy +10,000 $2.25 $22,500 On-market trade
01/11/23 Henry Townsing Transfer 102,594 $1.79 $183,643 As advised by the company
27/10/23 Peter Osborne Buy +6,700 $1.73 $11,591 On-market trade
25/10/23 Peter Osborne Buy +8,574 $1.73 $14,815 On-market trade
12/05/22 Henry Townsing Transfer 250,000 $1.75 $437,500 As advised by the company
12/05/22 Henry Townsing Transfer 250,000 $1.75 $437,500 As advised by the company
12/05/22 Henry Townsing Issued 300,000 $1.89 $567,000 Issue of securities
12/05/22 Andrew O'Keefe Issued 500,000 $1.89 $945,000 Issue of securities
29/04/22 Henry Townsing Transfer 9,000 $2.10 $18,900 As advised by the company
23/02/22 Henry Townsing Transfer 1,000 $2.15 $2,150 As advised by the company
23/02/22 Henry Townsing Sell +1,259 $1.92 ($2,418) As advised by the company
01/06/21 Andrew O'Keefe Issued 1,000,000 $0.900 $900,000 Issue of securities
08/04/21 Jonathan Tooth Sell +34,104 $1.05 ($35,872) As advised by the company
29/03/21 Andrew O'Keefe Cancelled 500,000 $1.000 $500,000 Cancellation of securities
29/03/21 Henry Townsing Cancelled 250,000 $1.000 $250,000 Cancellation of securities
11/03/21 Jonathan Tooth Issued 34,104 $1.000 $34,104 As advised by the company
22/06/20 Andrew O'Keefe Buy +10,000 $0.582 $5,824 On-market trade
24/04/20 Andrew O'Keefe Cancelled 500,000 $0.800 $400,000 Cancellation of securities
04/06/19 Henry Townsing Issued 500,000 $1.10 $550,000 Issue of securities
26/02/18 Andrew O'Keefe Cancelled 200,000 $0.750 $150,000 Cancellation of securities
26/02/18 Henry Townsing Sell +1,632 $1.52 ($2,481) On-market trade
26/02/18 Henry Townsing Cancelled 1,000,000 $0.750 $750,000 Cancellation of securities
22/06/17 Andrew O'Keefe Issued 1,000,000 $1.38 $1,380,000 As advised by the company
17/11/16 Vanda Gould Buy +8,551,439 $1.35 $11,544,443 As advised by the company
10/03/16 Henry Townsing Sell +37,500 $1.50 ($56,413) On-market trade
18/12/15 Vanda Gould Buy +20,000 $1.20 $24,000 On-market trade
02/11/15 Vanda Gould Buy +20,000 $1.11 $22,200 On-market trade
12/10/15 Lim Sung (Eddie) Tie Buy +33,000 $1.000 $33,000 Off-market trade
30/06/15 Lim Sung (Eddie) Tie Buy +400,000 $1.56 $624,000 Issue of securities
30/06/15 Henry Townsing Buy +1,000,000 $1.56 $1,560,000 Issue of securities
16/12/14 Henry Townsing Buy +463 $1.40 $648 On-market trade
15/12/14 Henry Townsing Buy +2,537 $1.40 $3,552 On-market trade
12/12/14 Henry Townsing Buy +1,700 $1.42 $2,414 On-market trade
11/12/14 Henry Townsing Buy +5,000 $1.42 $7,100 On-market trade
10/12/14 Henry Townsing Buy +3,300 $1.42 $4,686 On-market trade

Director Interests

The current holdings of VLS directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Andrew O'Keefe 12/04/2024 590,000 N/A N/A N/A
Henry Townsing 12/04/2024 15,270 794,744 N/A N/A
Peter Osborne 12/03/2024 25,274 N/A N/A N/A
Jack Teoh 30/09/2022 0 N/A N/A N/A

Shareholder Info

Top 20 Shareholders

Data supplied by Morningstar and accurate on Feb 28, 2023.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
Chemical Overseas Limited 8,551,439 15.10%
Vicky Teoh 8,435,693 14.90%
Barings Acceptance Limited 7,371,832 13.00%
Anglo Australian Christian & Charitable Fund 6,276,040 11.10%
Tie Lim Sung 4,340,366 7.70%
Hsbc Custody Nominees (Australia) Limited 2,521,141 4.50%
Andrew O'Keefe 1,510,000 2.70%
South Seas Holdings Pty Ltd 1,345,430 2.40%
Tan Teik Wei 811,607 1.40%
B F A Pty Ltd 637,591 1.10%
Chin L Khoo 606,000 1.10%
K S Beh 605,000 1.10%
Pacom Sdn Bhd 577,381 1.00%
Shaun Rutherford 525,000 0.90%
Jysf Management Pty Ltd 475,680 0.80%
G & E Properties Pty Ltd 442,876 0.80%
Redbrook Nominees Pty Ltd 363,375 0.70%
Stanton Lea Pty Ltd 354,741 0.60%
Gliocas Investments Pty Ltd 329,295 0.60%
Citicorp Nominees Pty Ltd 313,928 0.60%

Shareholder Distribution

As reported in the most recent Annual Report.

The most recent Annual Report didn't contain Shareholder Distribution data.

Substantial Shareholders

A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.

Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.

Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.

Name Last Notice Total Shares Shares Held (%)
Barings Acceptance Limited 28/02/2023 7,371,832 13.00
Anglo Australian Christtan and Charitable Fund 28/02/2023 6,276,040 11.10
Chemical Trustee Limited 28/02/2023 8,551,439 15.10
Tie Lim Sung 28/02/2023 4,340,366 7.70
Vicky Teoh 28/02/2023 8,435,693 14.90
SG Hiscock & Company Limited 09/02/2024 3,297,299 6.12

Shareholders Buying

12 month transaction history compiled from ASX announcements.

Date Name Bought Previous % New %
09-02-24 SG Hiscock & Company Limited 426,715 5.08 6.12
05-10-23 SG Hiscock & Company Limited 2,870,584 -- 5.08

Shareholders Selling

12 month transaction history compiled from ASX announcements.

No sell transactions reported by Substantial Shareholders in the past 12 months.

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
2023 $1.56 30 June
2022 $1.82 30 June
2021 $1.10 30 June
2020 $0.560 30 June
2019 $0.725 28 June
2018 $0.795 29 June
VLS Historical Price Data (CSV)
Up to 20 years of EOD share price history

Important note:

All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)

Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.